ContractSecurities Purchase Agreement • May 5th, 2020 • New York
EX-10.3 2 myovantex1036302018.htm EXHIBIT 10.3 Exhibit 10.3 Execution Version WAIVER AND AMENDMENT TO SECURITIES PURCHASE AGREEMENT This Waiver and Amendment to Securities Purchase Agreement (the “Waiver and Amendment”) is entered into as of the 28th day of March 2018, by and among Myovant Sciences Ltd., an exempted company incorporated and organized under the laws of Bermuda (“Issuer”), Myovant Holdings Limited, a company incorporated in England and Wales with registered number 10317663 (“Myovant England”), Myovant Sciences GmbH, a limited liability company (Gesellschaft mit beschränkter Haftung) incorporated and organized under the laws of Switzerland (“Myovant Switzerland”), Myovant Sciences Ireland Limited, a private company limited by shares organized under the laws of Ireland with registered number 601541 (“Myovant Ireland”), Myovant Sciences, Inc., a Delaware corporation (“Myovant Delaware” and, together with Myovant England, Myovant Switzerland and Myovant Ireland, each a “Guar